Work

La Ferroptose médiée par SOCS1 en tant que mécanisme de suppression tumorale dans le carcinome hépatocellulaire

Year: 2022
Type: dissertation
Abstract: Despite the latest improvements in screening and advanced treatment methods, clinical management of liver cancer still remains a challenge. Therefore, the poor prognosis of hepatocellular carcinoma (HCC) warrants the development of new treatments. Ferroptosis, a new form of regulated cell death may have therapeutic potential toward HCC. However, the determinants of ferroptosis susceptibility are not yet well understood. Many recent studies have shown that the system xc-, an antiporter involved in the import of cystine required for glutathione biosynthesis and antioxidant defense is exploited by cancer cells. Indeed, xCT overexpression in cancers can promote tumor growth by suppressing ferroptosis that is induced by excessive lipid peroxidation. Of particular interest is the SOCS1 protein, which is a tumor suppressor often silenced in HCC by epigenetic mechanisms. SOCS1 has the potential to regulate ferroptosis, and SOCS1-mediated ferroptosis could be exploited for treating hepatocellular carcinoma. The present study focuses on gaining a better understanding of the xCT - SOCS1 axis in HCC. HCC cell lines overexpressing SOCS1 were used to evaluate ferroptosis in cell death assays in vitro in the presence of ferroptosis inducers and inhibitors. Carbon tetrachloride (CCL4) was also used to induce oxidative stress in vivo in the livers of SOCS1-deficient mice. Immunocytochemistry, western blot and RT-qPCR were used to measure the levels of xCT expression. We provide evidence that the expression of xCT is repressed by SOCS1 at mRNA and protein levels in representative HCC cell lines in response to oxidative stress. SOCS1 overexpression rendered HCC cell lines susceptible to ferroptotic cell death. The expression of system xc- in the liver following ferroptosis induction by CCL4 in vivo is increased in SOCS1-deficient mice. These findings indicate that SOCS1 is a key regulator of ferroptosis through modulation of system xc- expression. Given that SOCS1 is repressed in HCC and SOCS1 deficiency in mice increases susceptibility to experimental HCC, our findings suggest that restoring SOCS1 expression could be a potential approach to therapeutically modulate the ferroptosis susceptibility of HCC cases that are refractory to other treatments.
Language: English
Subfield: Cancer Research
Open Access status: green
OpenAlex ID: W7201947998
Cites: 247
Cited by:
Related to: 10